Pettyjohn Wood & White’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.65M Buy
19,047
+240
+1% +$23K 0.26% 72
2025
Q4
$1.81M Buy
18,807
+36
+0.2% +$3.5K 0.28% 71
2025
Q3
$1.79M Buy
18,771
+133
+0.7% +$12.2K 0.3% 72
2025
Q2
$1.62M Sell
18,638
-1,383
-7% -$117K 0.29% 74
2025
Q1
$1.8M Sell
20,021
-205
-1% -$18.3K 0.34% 66
2024
Q4
$1.62M Sell
20,226
-1,450
-7% -$126K 0.3% 70
2024
Q3
$1.95M Sell
21,676
-837
-4% -$70.4K 0.36% 62
2024
Q2
$1.77M Sell
22,513
-776
-3% -$63.6K 0.34% 63
2024
Q1
$2.03M Sell
23,289
-2,878
-11% -$246K 0.4% 60
2023
Q4
$2.16M Sell
26,167
-5,846
-18% -$446K 0.47% 52
2023
Q3
$2.51M Sell
32,013
-3,922
-11% -$328K 0.59% 47
2023
Q2
$3.17M Sell
35,935
-675
-2% -$58.1K 0.73% 40
2023
Q1
$2.95M Sell
36,610
-61
-0.2% -$4.97K 0.72% 41
2022
Q4
$2.85M Sell
36,671
-2,210
-6% -$179K 0.71% 44
2022
Q3
$3.14M Buy
38,881
+629
+2% +$56.5K 0.84% 37
2022
Q2
$3.43M Buy
38,252
+816
+2% +$82.7K 0.81% 40
2022
Q1
$4.15M Buy
37,436
+310
+0.8% +$32.8K 0.89% 40
2021
Q4
$3.84M Buy
37,126
+1,182
+3% +$137K 0.79% 42
2021
Q3
$4.51M Buy
35,944
+62
+0.2% +$8.03K 1% 39
2021
Q2
$4.45M Buy
35,882
+125
+0.3% +$15.7K 1% 38
2021
Q1
$4.22M Buy
35,757
+650
+2% +$76.2K 1% 38
2020
Q4
$4.11M Buy
35,107
+795
+2% +$87.5K 1.05% 34
2020
Q3
$3.57M Sell
34,312
-119
-0.3% -$12K 1.04% 34
2020
Q2
$3.16M Buy
34,431
+3,175
+10% +$304K 1.01% 38
2020
Q1
$2.82M Buy
31,256
+2,503
+9% +$266K 1.05% 31
2019
Q4
$3.26M Sell
28,753
-100
-0.3% -$11K 0.94% 37
2019
Q3
$3.13M Sell
28,853
-200
-0.7% -$20.9K 0.95% 38
2019
Q2
$2.83M Buy
29,053
+5,380
+23% +$491K 0.88% 39
2019
Q1
$2.16M Buy
23,673
+4,665
+25% +$418K 0.7% 47
2018
Q4
$1.73M Buy
19,008
+1,115
+6% +$104K 0.63% 49
2018
Q3
$1.76M Buy
17,893
+1,130
+7% +$104K 0.57% 51
2018
Q2
$1.44M Buy
+16,763
New +$1.4M 0.5% 60

Other funds holding MDT

Pettyjohn Wood & White's MDT Position: Q1 2026 in Review

Pettyjohn Wood & White increased its Medtronic (MDT) stake by 1.3% in Q1 2026, buying an estimated $23K and bringing the position to 19,047 shares worth $1.65M. The position accounts for 0.26% of the portfolio, ranked #72.

Pettyjohn Wood & White first reported a position in MDT in Q2 2018 and has held it in 32 quarters since. The position peaked at $4.51M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Pettyjohn Wood & White held 19,047 shares of Medtronic worth $1.65M as of Q1 2026.
  • Pettyjohn Wood & White bought 240 Medtronic shares in Q1 2026, an estimated $23K.
  • Medtronic made up 0.26% of Pettyjohn Wood & White's portfolio in Q1 2026, its #72 holding.
  • Pettyjohn Wood & White first reported a position in Medtronic in Q2 2018 and has held it in 32 quarters since.
  • Pettyjohn Wood & White's Medtronic position peaked at $4.51M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Pettyjohn Wood & White's 13F filing for Q1 2026, filed 15 May 2026.